LanguageTerm (authority = ISO 639-3:2007); (type = text)
English
Abstract (type = abstract)
Over the past several decades, mesoporous silica nanoparticles (MSNs) have attracted a tremendous deal of interest in areas such as catalysis, drug delivery systems (DDSs), sensing, environmental remediation, and nanoelectronics due to their unique structures and properties. Since their discovery, research focused on MSN-based drug delivery systems has increased exponentially each year.1 The current body of work utilizes MSNs as a delivery vehicle to host a variety of quaternary ammonium compounds (QACs) for biomedical applications. The results reported herein demonstrate that the combination of porous materials with QACs can have a significant synergistic effect on the antimicrobial properties of the resulting material which paves the way for further studies to build upon this enhancing effect.
In chapter 2, benzalkonium chloride (BAC) was used as a template to synthesize mesostructured silica nanoparticles for antimicrobial applications.1 The synthesized material comprised a relatively high density (0.56 g per 1 g of SiO2) of BAC and a high surface area (1500 m2 g-1) after calcination. In the physiologically-relevant pH range of 4.0 to 7.4, BAC was released in a controlled manner showing dependence between pH and rate of release. The material demonstrated inhibition of the gram-positive Staphylococcus aureus and the gram-negative Salmonella enterica at 10 and 130 mg/L, respectively. Taking into consideration a ca. 36 wt.% loading content of BAC within the BAC-SiO2 material, this correlates to an inhibition of S. aureus with 4 mg/L BAC which is a 10-fold enhancement compared to the minimum inhibitory concentration (MIC) of 40 mg/L for pure BAC. These results indicate that either the release of an antimicrobial drug (e.g., BAC) from the MSNs is not mandatory to achieve bactericidal efficacy or the host-guest relationship between BAC and silica MSNs boosts antimicrobial activity.
In chapter 3, cetylpyridinium chloride (CPC) was complexed with ZnCl2 to yield cetylpyridinium tetrachlorozincate with a stoichiometry of C42H76Cl4N2Zn where zinc exists as [ZnCl4]2- tetrahedra. This novel material demonstrated parity antimicrobial efficacy as compared to pure CPC despite the fact that ca. 16% of the material is replaced with bacteriostatic ZnCl2. A technique to load the novel material into porous frameworks was proposed and yielded a material with ca. 9.0 and 8.9 wt.% of CPC and Zn, respectively.
In chapter 4, a complex comprising chlorhexidine (CHX) with N-cyclohexylsulfamate (i.e., cyclamate) was synthesized yielding a stoichiometry of [C22H32N10Cl2][C7H13O3S]2. This newly discovered material demonstrates excellent antimicrobial activity with a minimum inhibitory concentration (MIC) of 2.5 µg/mL for Streptococcus mutans. Moreover, this material is advantageous as compared to the indispensable chlorhexidine gluconate since the inactive gluconate ion is substituted with the bioactive artificial sweetener (i.e., cyclamate) which has the potential to mitigate the bitter taste commonly associated with chlorhexidine.
Subject (authority = local)
Topic
Antimicrobial
Subject (authority = LCSH)
Topic
Anti-infective agents
Subject (authority = RUETD)
Topic
Chemistry and Chemical Biology
RelatedItem (type = host)
TitleInfo
Title
Rutgers University Electronic Theses and Dissertations
Identifier (type = RULIB)
ETD
Identifier
ETD_10650
PhysicalDescription
Form (authority = gmd)
InternetMediaType
application/pdf
InternetMediaType
text/xml
Extent
1 online resource (xv, 156 pages) : illustrations
Note (type = degree)
Ph.D.
Note (type = bibliography)
Includes bibliographical references
RelatedItem (type = host)
TitleInfo
Title
School of Graduate Studies Electronic Theses and Dissertations
Identifier (type = local)
rucore10001600001
Location
PhysicalLocation (authority = marcorg); (displayLabel = Rutgers, The State University of New Jersey)
I hereby grant to the Rutgers University Libraries and to my school the non-exclusive right to archive, reproduce and distribute my thesis or dissertation, in whole or in part, and/or my abstract, in whole or in part, in and from an electronic format, subject to the release date subsequently stipulated in this submittal form and approved by my school. I represent and stipulate that the thesis or dissertation and its abstract are my original work, that they do not infringe or violate any rights of others, and that I make these grants as the sole owner of the rights to my thesis or dissertation and its abstract. I represent that I have obtained written permissions, when necessary, from the owner(s) of each third party copyrighted matter to be included in my thesis or dissertation and will supply copies of such upon request by my school. I acknowledge that RU ETD and my school will not distribute my thesis or dissertation or its abstract if, in their reasonable judgment, they believe all such rights have not been secured. I acknowledge that I retain ownership rights to the copyright of my work. I also retain the right to use all or part of this thesis or dissertation in future works, such as articles or books.